Bibliography
Found 365 results
Filters: Keyword is Internal [Clear All Filters]
Problematic Prescription Opioid Use in an HIV-Infected Cohort: The Importance of Universal Toxicology Testing. J Acquir Immune Defic Syndr [Internet]. 2012 . Available from: http://www.ncbi.nlm.nih.gov/pubmed/22820804
. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012 ;78(7):485-92.
Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 ;56(4):1985-9.
.
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011 ;17(3):248-57.
Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 ;52(4):328-32.
A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers. Neurobehav HIV Med. 2011 ;3:79-86.
. . Demographically Corrected Norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol. [Internet]. 2011 ;33:793-804. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154384/
. Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother. 2011 ;66(2):354-7.
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci. 2011 ;23(3):316-23.
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 ;17(1):3-16.
Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 ;17(1):50-7.
Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr. 2011 ;58(2):154-62.
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011 ;33(5):505-22.
Weighted gene co-expression network analysis of NeuroAIDS cognitive disorders. In: Summit on Systems Biology. Summit on Systems Biology. Richmond, VA; 2011.
. Assessment of the NEUROPSI in Detecting Neurocognitive Deficits in HIV+ Spanish Speakers. In: 38th annual meeting of the International Neuropsychological Society. 38th annual meeting of the International Neuropsychological Society. Acapulco, Mexico; 2010.
. Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain. 2010 ;151(3):732-6.
Comparing the accuracy of neuropsychological testing methods in determining neurocognitive impairment in HIV-infected Spanish speaking adults. In: UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. UCLA Neuroscience Undergraduate Interdepartmental Program 11th Annual Poster Session. Los Angeles, CA; 2010.
. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010 ;67(5):552-8.
Hematopathology of HIV infection. In: Hematopathology. Hematopathology. ; 2010.
. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010 ;75(23):2087-96.
Management of Acquired Immunodeficiency Syndrome-Related Lymphoma. In: Non-Hodgkin Lymphoma. Second Edition. Non-Hodgkin Lymphoma. Philadelphia: Wolters Kluower Lipincott William & Wilkins; 2010.
. .